Physician profile
Regina M Fearmonti
NPI 1750488276
$339,922.36
in general payments reported to CMS, 2019-2025
26 companies · $99K in 2025
The $99K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $15K · 2021: $31K · 2022: $28K · 2023: $66K · 2024: $67K · 2025: $99K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $187K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $10K · Food and Beverage: $8,912 · Honoraria: $8,400 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $187,122.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,412.50 |
| Travel and Lodging | $10,350.00 |
| Food and Beverage | $8,911.75 |
| Honoraria | $8,400.00 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $164,217.58 | 2019-2025 | |
| Kci USA, INC. | $117,420.22 | 2019-2023 | Prevena, Prevena Restor Bellaform, V.A.C. Veraflo |
| Solventum Corporation | $33,408.31 | 2024-2025 | Prevena, V.A.C. Veraflo, Prevena Restor Bellaform |
| Rti Surgical, INC | $8,400.00 | 2024-2025 | |
| Motiva USA, LLC | $3,786.57 | 2024-2025 | |
| Merz North America, INC. | $3,656.97 | 2019-2025 | |
| Stryker Corporation | $1,412.81 | 2019-2023 | Spy-Phi System, 1688 |
| Smith+Nephew, INC. | $1,210.00 | 2021 | |
| Tela Bio, INC. | $914.24 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $874.44 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Medical Device Business Services, INC. | $840.15 | 2019 | |
| W. L. Gore & Associates, INC. | $700.00 | 2024 | Product In Development |
| Ets Wound Care LLC | $592.29 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Somavac Medical Solutions, INC. | $406.45 | 2025 | Somavac 100 Sustained Vacuum System |
| Tepha INC | $379.65 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $270.11 | 2022 | |
| Zyla Life Sciences, INC. | $207.06 | 2019-2020 | |
| Allergan, INC. | $205.45 | 2019-2020 | |
| Galderma Laboratories, L.P. | $160.87 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $154.52 | 2021 | |
| Revance Therapeutics, INC. | $145.73 | 2024 | Daxi |
| Abbvie INC. | $142.69 | 2024 | |
| Becton, Dickinson and Company | $125.62 | 2025 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $124.14 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $121.13 | 2019 | |
| Convatec INC. | $45.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Fearmonti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.